scholarly article | Q13442814 |
P356 | DOI | 10.1002/GPS.1306 |
P698 | PubMed publication ID | 15852458 |
P2093 | author name string | Adams C | |
Prasher VP | |||
Fung N | |||
P2860 | cites work | Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population | Q35813930 |
A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Down syndrome and Alzheimer's disease--pilot study. | Q43938550 | ||
Down syndrome and Alzheimer disease: response to donepezil | Q44063664 | ||
Cholinergic therapy for Down's syndrome | Q77310745 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Alzheimer's disease | Q11081 |
dementia | Q83030 | ||
P304 | page(s) | 496-497 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | International Journal of Geriatric Psychiatry | Q6051406 |
P1476 | title | Rivastigmine in the treatment of dementia in Alzheimer's disease in adults with Down syndrome | |
P478 | volume | 20 |
Q33726997 | Certainty of genuine treatment increases drug responses among intellectually disabled patients |
Q90531305 | Challenges faced in managing dementia in Alzheimer's disease in patients with Down syndrome |
Q37217895 | Cholinergic components of frontal lobe function and dysfunction |
Q38865366 | Dementia in Down's syndrome |
Q48287894 | Down syndrome: the brain in trisomic mode |
Q38312346 | Pharmacological management of behavioral and psychiatric symptoms in older adults with intellectual disability |
Q22252965 | Rivastigmine for dementia in people with Down syndrome |
Q85849603 | Rivastigmine transdermal patches in the treatment of dementia in Alzheimer's disease in adults with Down syndrome-pilot study |
Q35087290 | Safety and efficacy of rivastigmine in adolescents with Down syndrome: a preliminary 20-week, open-label study |
Q51930325 | The efficacy, safety, and tolerability of donepezil for the treatment of young adults with Down syndrome. |
Q33770940 | Toward onset prevention of cognitive decline in adults with Down syndrome (the TOP-COG study): study protocol for a randomized controlled trial |
Search more.